Blueprint for heart and vascular health? What research says

No. There is no published clinical trial showing that Bryan Johnson’s Blueprint supplements or the retail Blueprint stack improves men’s heart, vascular, endothelial glycocalyx, or sexual health. The Blueprint Stack is a $361 per month breakfast and supplement bundle that delivers about 400 calories, 26 g of plant protein, and roughly eight daily pills, so most Blueprint supplement reviews are still ingredient extrapolations, not proven outcomes.
Find the cause before treating it
Choose a lab panel and get a written report from our medical team.
Key takeaways
- The public Blueprint stack costs $361 for 30 days, about $12 per day, and covers breakfast plus supplements, not Bryan Johnson’s full supplement stack or entire Blueprint protocol.
- Blueprint’s commercial breakfast provides about 400 calories, Nutty Pudding supplies 26 g of plant protein, and Longevity Mix includes 2,500 mg of creatine.
- Bryan Johnson has described a personal routine involving 100 plus supplements, but the retail Blueprint stack condenses that into powders, olive oil, and roughly eight pills per day.
- Evidence supports parts of the food pattern, especially extra virgin olive oil and nuts in Mediterranean diets, but there is no published randomized trial of the complete Blueprint supplement stack in men.[1]
- For men with erection or libido complaints, vascular health and hormone health overlap, and proper testing should include blood pressure, glucose, lipids, and morning Total Testosterone, Free Testosterone, LH, and FSH when symptoms suggest hypogonadism.
What Blueprint is really selling
Blueprint is Bryan Johnson’s retail line of foods and supplements. It is not a validated medical program for endothelial health, nitric oxide, glycocalyx support, or heart disease prevention.
The products sold to consumers are much smaller in scope than his personal routine. The public version centers on Nutty Pudding, Longevity Mix, nuts, olive oil, and pill packs. Published reporting on the retail bundle puts the cost at $361 per month, with about 400 breakfast calories and roughly eight pills per day, so most reviews of it are reviewing a branded breakfast routine more than a medical protocol.
Any fair assessment has to separate evidence for the foods from evidence for the products. Extra virgin olive oil and nuts are part of a Mediterranean pattern linked to lower cardiovascular risk.[1] [2] Blueprint’s 2,500 mg creatine dose is slightly below the 3 to 5 g per day typically used in studies. According to the International Society of Sports Nutrition position stand, creatine’s strongest evidence is for high-intensity exercise performance and training adaptations.[3] That evidence says nothing about endothelial repair or libido.
How the stack maps to real physiology
The ingredients touch real biology, but the strength of evidence differs widely by pathway.
Heart and cardiovascular support
The strongest cardiovascular case for Blueprint comes from its Mediterranean-style foods, not its branded pills. In a 2014 BMC Medicine observational analysis of the PREDIMED trial, which followed 7,216 men and women aged 55 to 80 at high cardiovascular risk for a median of 4.8 years, those in the highest third of extra virgin olive oil intake had a 39% lower risk of cardiovascular disease than those in the lowest third.[1] A 2019 review in Circulation Research of 45 prospective studies concluded that closer adherence to the Mediterranean diet is associated with lower rates of coronary heart disease, ischemic stroke, and total cardiovascular disease.[2] That puts Blueprint’s olive oil, walnuts, and macadamias on firmer ground than most longevity supplements.
According to a 2006 Annals of Internal Medicine trial in 772 adults at high cardiovascular risk, three months of a Mediterranean diet with added olive oil or nuts lowered systolic blood pressure by about 6 to 7 mm Hg compared with a low-fat diet, and also improved fasting glucose and the ratio of total to HDL cholesterol.[4] No randomized trial has shown that the full retail stack lowers heart attack risk, improves vascular age, or extends life in men.
Vascular endothelium and nitric oxide
Inorganic nitrate can lower blood pressure modestly, but Blueprint has no finished product trial showing nitric oxide or endothelial benefit in men. The endothelium is the thin inner lining of blood vessels, and nitric oxide is one of its main signals for vessel relaxation. A 2013 Journal of Nutrition meta-analysis pooled 16 short crossover trials with 254 participants and found that inorganic nitrate or beetroot juice lowered systolic blood pressure by about 4.4 mm Hg.[5] The 1.1 mm Hg fall in diastolic pressure was not statistically significant, larger daily nitrate doses were associated with larger systolic reductions, and the interventions lasted only 2 hours to 15 days.[5]
If a nitric oxide product does not publish its active nitrate dose and a human outcome study of the finished formula, its claims about circulation or microcirculation are borrowed from the general beetroot and nitrate literature rather than shown for the product itself.
Endothelial glycocalyx and intestinal glycocalyx
Endothelial glycocalyx support is a mechanism-level claim, not a clinically proven outcome in men. The endothelial glycocalyx is a mesh of membrane-bound proteoglycans and glycoproteins that coats the inside of blood vessels. A 2007 review in Pflügers Archiv describes its roles in mechanotransduction, hemostasis, signaling, and interactions between blood cells and the vessel wall, and notes that reliably visualizing this delicate layer is itself a major challenge.[6] Intestinal cells carry their own glycocalyx, which is a separate structure.
That biology explains why glycocalyx language appears in Blueprint marketing, but published human trials showing that a specific Blueprint supplement restores the endothelial or intestinal glycocalyx in men are not publicly available. Ingredients often discussed in this space, including hyaluronic acid, fucoidan, and rhamnan sulfate from Monostroma nitidum, remain more interesting mechanistically than proven clinically.
Circulation, microcirculation, and erectile function
Erections depend on penile blood flow and endothelial health, so claims about circulation, nitric oxide, and sexual function all point to the same vessels. Erectile dysfunction is also linked to higher cardiovascular risk, which is why lasting erection problems are a medical signal, not a supplement shopping problem.[7]
According to the 2021 European Association of Urology guideline on male sexual dysfunction, men with erectile dysfunction should have a structured diagnostic workup that includes cardiovascular and metabolic risk factors, and phosphodiesterase type 5 inhibitors such as tadalafil are an established treatment.[8] Searches for a “Bryan Johnson Cialis” protocol blur two categories. Cialis is the brand name for tadalafil, a prescription drug, while Blueprint is a supplement stack with no published trial showing it enhances tadalafil or replaces a medical workup.
If libido, erection quality, or energy are also low, hormone testing may be appropriate. The European Association of Urology guideline defines late-onset hypogonadism as low circulating testosterone combined with specific symptoms, so a low number alone is not a diagnosis.[8] According to the 2018 American Urological Association guideline, low testosterone should be confirmed with two early morning total testosterone measurements on separate days, and LH should be measured in men with low testosterone to help classify the cause.[9] FSH belongs alongside LH, because together they separate primary hypogonadism, where the testes fail, from secondary hypogonadism, where the brain does not signal enough, and that distinction determines treatment.
Gut health, IBS, SIBO, and unclear branded products
Gut symptoms need diagnosis first, because IBS, SIBO, reflux, medication effects, and simple supplement intolerance can look similar. A star rating or unboxing video cannot show whether a product helps any of them.
Public evidence for Blueprint’s gut products is much thinner than the evidence for whole dietary patterns. A credible claim about gut repair would need a trial of the finished product, a stated dose, and a defined symptom end point.
Which male conditions these claims actually touch
The pathways Blueprint talks about are most relevant to hypertension, early endothelial dysfunction, erectile dysfunction, and broader cardiometabolic disease in men.
Hypertension and early vascular disease. In the short trials pooled in the nitrate meta-analysis, systolic blood pressure fell by about 4 mm Hg, and the authors noted that the findings still need testing in long-term trials and in people at greater cardiovascular risk.[5] A change of that size does not offset obesity, smoking, sleep apnea, or insulin resistance, and direct human evidence for branded glycocalyx supplements remains limited compared with the evidence for Mediterranean diet patterns, blood pressure control, and standard ED care.
Erectile dysfunction. A 2013 meta-analysis in Circulation: Cardiovascular Quality and Outcomes, covering 14 cohort studies with 92,757 participants, found that men with erectile dysfunction had a 44% higher risk of cardiovascular events and a 25% higher risk of death from any cause than men without it.[7] The relative risk was higher in younger men and in those at intermediate cardiovascular risk.[7] Ongoing ED is a vascular clue, and first-line care rests on diagnosis, risk factor control, and proven therapy.
Cardiometabolic overload. The useful test for any heart or gut claim is whether the product improves measurable end points such as blood pressure, fasting glucose, waist size, LDL cholesterol, exercise tolerance, or erection quality. Without those end points, the claim is marketing language.
Supplement intolerance. Reporting on Blueprint noted that users are advised to phase in products gradually because gastrointestinal side effects can occur. Large pill packs, minerals, concentrated plant extracts, and multi-ingredient drink mixes commonly cause nausea, bloating, or loose stools, especially on an empty stomach.
Signs a man should watch for
Problems usually show up as patterns over weeks rather than as a single event.
- Your home blood pressure is repeatedly at or above 130 over 80, or you see a clear upward trend after months of “heart health” supplementation.
- Your morning erections are less frequent, softer, or shorter lasting for several weeks, especially if exercise tolerance or libido also slipped.
- You need more stimulation than before to get or keep an erection, or intercourse fails more often under ordinary conditions, not just after a bad night of sleep.
- You feel flushed, headachy, lightheaded, or jittery after nitric oxide boosters, especially if you also use tadalafil or blood pressure medication.
- You develop bloating, nausea, reflux, cramping, or loose stools soon after adding Longevity Mix, pill packs, or several Blueprint supplements at once.
- You keep buying products because reviews promise “microcirculation” gains that you cannot measure.
- You are relying on supplement claims instead of checking lipids, glucose, kidney function, and, if symptoms fit, morning Total Testosterone, Free Testosterone, LH, and FSH.
- You are following the Bryan Johnson Blueprint protocol or supplement stack without checking whether any specific change improved a real health end point.
Myth vs fact
Myth: If a product boosts nitric oxide, it will fix erections.
Fact: Nitric oxide matters for penile blood flow, but erectile dysfunction often has several causes, including vascular disease, medication effects, anxiety, sleep loss, diabetes, or hypogonadism. The European Association of Urology guideline sets out a diagnostic workup for erectile dysfunction before treatment is chosen.[8]
Myth: Bryan Johnson Blueprint supplements’ endothelial glycocalyx claims are proven because the science of the glycocalyx is real.
Fact: The endothelial glycocalyx is a real structure with important vascular functions.[6] That does not show that a branded glycocalyx supplement rebuilds it in men. Mechanism-level biology is not product-level evidence.
Myth: The retail Blueprint stack is the same thing as Bryan Johnson’s full supplement stack.
Fact: The retail Blueprint stack is a simplified consumer bundle. Bryan Johnson has described a much larger personal routine, so the public product line should not be assumed to reproduce everything he does.
Myth: More longevity supplements always mean better heart health.
Fact: Some ingredients in Blueprint have plausible benefits, but unnecessary stacking adds cost, side effects, or nutrient excess without extra benefit. Olive oil intake and the Mediterranean diet have been linked to fewer cardiovascular events in large prospective studies.[1] [2] Most add-ons in the stack have no comparable outcome data.
Myth: A premium stack makes lab work less important.
Fact: Supplements do not replace diagnosis. Men with fatigue, low libido, or erection changes need objective data. Hypogonadism requires symptoms plus low testosterone, and LH with FSH must be measured to classify primary vs secondary causes. TRT is a treatment for documented hypogonadism, not an anti-aging shortcut. The TRAVERSE trial, published in 2023 in the New England Journal of Medicine, enrolled 5,246 men aged 45 to 80 with symptoms of hypogonadism, two fasting testosterone levels below 300 ng/dL, and existing or high cardiovascular risk.[10] Over a mean follow-up of 33 months, testosterone gel was noninferior to placebo for major cardiovascular events, although atrial fibrillation, acute kidney injury, and pulmonary embolism were more common with testosterone.[10] Those results apply to men with confirmed hypogonadism, not to men with normal levels.
What to do before you buy or stack more products
Start with measurable health goals, not with the product page.
- Step 1: Audit the finished product, not just the theory. For any claim about nitric oxide, circulation, gut health, or glycocalyx support, look for four things: the exact dose, a human trial of the actual finished product, the end point that improved, and the size of the effect.
- Step 2: Check the markers that matter. Track home blood pressure, fasting glucose or A1c, lipids, waist size, exercise capacity, and erection quality. If symptoms suggest a hormone problem, get a morning male panel drawn between about 7 and 11 a.m. that includes total testosterone, free testosterone, LH, and FSH.
- Step 3: Treat diagnosable problems before adding more products. Primary hypogonadism, with high LH and low testosterone, usually needs TRT because the testes cannot respond to more signaling, and TRT suppresses sperm production, so it does not suit men trying to conceive. Options for secondary or functional hypogonadism include weight loss, medication review, treating the underlying condition, and medicines such as enclomiphene that raise the body’s own testosterone production.
Veedma offers morning testing that includes total and free testosterone measured by LC-MS/MS with LH and FSH, or a review of labs you already have, interpreted by licensed providers nationwide. When appropriate, those providers may prescribe enclomiphene or the enclomiphene plus tadalafil tablet. Enclomiphene is not an FDA-approved drug; it is prescribed after a provider confirms the diagnosis and is compounded by a licensed U.S. pharmacy.
Bottom line
Blueprint is an expensive supplement and food system with some evidence-aligned foods and several plausible ingredients, but there is no published evidence that the full Bryan Johnson Blueprint stack improves men’s cardiovascular health, endothelial function, glycocalyx integrity, circulation, or sexual function. It is a real supplement brand, not a proven shortcut, and blood pressure, metabolic markers, and a proper workup for erection or hormone symptoms remain the better guide.
References
- Guasch-Ferré M, Hu FB, Martínez-González MA, et al. Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study. BMC Med. 2014;12:78. PMID: 24886626
- Martínez-González MA, Gea A, Ruiz-Canela M. The Mediterranean Diet and Cardiovascular Health. Circ Res. 2019;124:779-798. PMID: 30817261
- Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18. PMID: 28615996
- Estruch R, Martínez-González MA, Corella D, et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 2006;145:1-11. PMID: 16818923
- Siervo M, Lara J, Ogbonmwan I, et al. Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. J Nutr. 2013;143:818-26. PMID: 23596162
- Reitsma S, Slaaf DW, Vink H, et al. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007;454:345-59. PMID: 17256154
- Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK, et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes. 2013;6:99-109. PMID: 23300267
- Salonia A, Bettocchi C, Boeri L, et al. European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction. Eur Urol. 2021;80:333-357. PMID: 34183196
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200:423-432. PMID: 29601923
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023;389:107-117. PMID: 37326322
Low energy, low libido, or brain fog?
Order your lab panelStart with a lab panel
Find out what is behind your symptoms. The panel includes a written report and, if the report shows a treatment path, a video visit with a licensed doctor.
Order your lab panel
Veedma's editorial team: Evidence-based men's health
The Veedma editorial team writes evidence-based men's health content with AI-assisted research tools, under clinical rules set by Vladimir Kotlov, MD, urologist, CEO and founder of Veedma. Every article passes automated checks before publication and is re-checked periodically. Read our editorial policy.